The effect of cholecystokinin antagonism on postprandial lower oesophagealsphincter function in asymptomatic volunteers and patients with reflux disease

Citation
Nj. Trudgill et al., The effect of cholecystokinin antagonism on postprandial lower oesophagealsphincter function in asymptomatic volunteers and patients with reflux disease, ALIM PHARM, 15(9), 2001, pp. 1357-1364
Citations number
25
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Pharmacology,"da verificare
Journal title
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
ISSN journal
0269-2813 → ACNP
Volume
15
Issue
9
Year of publication
2001
Pages
1357 - 1364
Database
ISI
SICI code
0269-2813(200109)15:9<1357:TEOCAO>2.0.ZU;2-V
Abstract
Background: Postprandial acid reflux is thought to be mediated by the incre ase in transient lower oesophageal sphincter relaxations (TLOSR) frequency and fall in lower oesophageal sphincter (LOS) pressure seen after ingestion of a meal, Studies in animals and healthy volunteers suggest that cholecys tokinin (CCK) may play a role. Aim: To study the role of CCK in postprandial LOS function using the CCK an tagonist loxiglumide. Subjects: 10 asymptomatic volunteers (7 male, 20-29 y ears) and 9 patients with symptomatic gastrooesophageal reflux (4 male, 33- 66 years). Methods: Oesophageal, LOS and gastric pressure and oesophageal pH readings were recorded for 1 h before and 2 h after intragastric, infusion of a 200 kCal, 300 mL long chain triglyceride meal. Each subject underwent two studi es and received intravenous loxiglumide or placebo infusion in randomized o rder. Results: During placebo infusion, postprandial LOS pressure fell [volunteer s: 17 (9-31) to 7 (1-19) mmHg (P < 0.01), patients: 15 (6-26) to 9 (2-21) m mHg (P = 0.02)] and TLOSR frequency increased [volunteers: 0 (0-1) to 2 (0- 7) per hour (P 0.01), patients: 0 (0-3) to 2 (0-10) per hour (P 0.03)]. Lox iglumide infusion attenuated the postprandial fall in LOS pressure and the postprandial increase in TLOSR frequency [volunteers: 0 (0-3) per hour (P = 0.04 vs. placebo), patients: 0 (0-2) per hour (P = 0.03 vs. placebo)], but it had only modest effects on postprandial acid exposure [volunteers: plac ebo 45 (0-1725) vs. loxiglumide 0 (0-443) seconds (N.S.), patients: placebo 60 (0-3442) seconds vs. loxiglumide 31 (0-1472) seconds (N.S.)]. Conclusions: Loxiglumide inhibits TLOSR and attenuates the fall in LOS pres sure following a meal, but has only modest effects on postprandial gastro-o esophageal acid reflux.